Suchergebnisse - "Takizawa, Hajime"

PubPharm (280)

1

Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy

enthalten in: Scientific reports | 2023

von Kataoka, K. | Oda, K. | Takizawa, H. | +20

2

Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs

enthalten in: Allergy | 2022

von Watanabe, M. | Nakamoto, K. | Inui, T. | +16

3

Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias

enthalten in: Thorax | 2022

von Enomoto, N. | Homma, S. | Inase, N. | +33

4

Crucial role of stimulator of interferon genes-dependent signaling in house dust mite extract-induced IgE production

enthalten in: Scientific reports | 2021

von Nunokawa, H. | Murakami, Y. | Ishii, T. | +4

5

Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells : A potential therapeutic agent for severe eosinophilic asthma

enthalten in: Immunity, inflammation and disease | 2021

von Sada, M. | Watanabe, M. | Inui, T. | +9

6

Dual interleukin-17A/F deficiency protects against acute and chronic response to cigarette smoke exposure in mice

enthalten in: Scientific reports | 2021

von Wada, H. | Nakamura, M. | Inoue, S. | +9

7

Immune-related adverse events with immune checkpoint inhibitors : Special reference to the effects on the lungs

enthalten in: Medicine | 2021

von Hirata, A. | Saraya, T. | Kobayashi, F. | +14

8

A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients

enthalten in: Medicine | 2021

von Ogawa, Y. | Saraya, T. | Noda, A. | +12

9

Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis : a randomised trial

enthalten in: The European respiratory journal | 2021

von Sakamoto, S. | Kataoka, K. | Kondoh, Y. | +21

CommentIn: Eur Respir J. 2021 Jan 5;57(1):. - PMID 33402374

10

Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells : A potential therapeutic agent for severe eosinophilic asthma

enthalten in: Immunity, Inflammation and Disease | 2021

von Sada, M. | Watanabe, M. | Inui, T. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]